Chapel Hill, NC, United States of America

Jeffrey Edmond Cobb


Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 14(Granted Patents)


Company Filing History:


Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Jeffrey Edmond Cobb

Introduction: Jeffrey Edmond Cobb is an accomplished inventor based in Chapel Hill, North Carolina. With a notable patent to his name, Cobb has made significant strides in the field of pharmaceutical innovations, particularly with compounds that have therapeutic potential.

Latest Patents: Cobb holds a patent for "Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to PPAR-gamma." This compound has a complex structure that involves various groups, including phenyl and heterocyclic components. The detailed formula suggests numerous possibilities for substitution and customization, making it a promising candidate for medicinal applications focusing on PPAR-gamma agonism.

Career Highlights: Cobb is currently associated with Glaxo Wellcome Inc., where his work involves advancing pharmaceutical formulations and compounds. His expertise and innovative mindset contribute to the ongoing development of effective medications within the company.

Collaborations: Throughout his career, Cobb has worked alongside other talented professionals, including Timothy Mark Willson. Their collaborative efforts likely foster significant advancements in their field, as teamwork often leads to the creation of groundbreaking innovations.

Conclusion: Jeffrey Edmond Cobb's contributions to the field of pharmaceuticals illustrate the impactful role of inventors in developing new therapeutics. His patent represents a significant achievement, furthering our understanding of complex compounds and their potential benefits. As Cobb continues his work at Glaxo Wellcome Inc., the future of innovative medical solutions remains bright.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…